Literature DB >> 28586221

The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.

Katie L Strong1, Matthew P Epplin1, John Bacsa1, Christopher J Butch1,2, Pieter B Burger1, David S Menaldino1, Stephen F Traynelis3, Dennis C Liotta3.   

Abstract

We have identified a series of positive allosteric NMDA receptor (NMDAR) modulators derived from a known class of GluN2C/D-selective tetrahydroisoquinoline analogues that includes CIQ. The prototypical compound of this series contains a single isopropoxy moiety in place of the two methoxy substituents present in CIQ. Modifications of this isopropoxy-containing scaffold led to the identification of analogues with enhanced activity at the GluN2B subunit. We identified molecules that potentiate the response of GluN2B/GluN2C/GluN2D, GluN2B/GluN2C, and GluN2C/GluN2D-containing NMDARs to maximally effective concentrations of agonist. Multiple compounds potentiate the response of NMDARs with submicromolar EC50 values. Analysis of enantiomeric pairs revealed that the S-(-) enantiomer is active at the GluN2B, GluN2C, and/or GluN2D subunits, whereas the R-(+) enantiomer is only active at GluN2C/D subunits. These results provide a starting point for the development of selective positive allosteric modulators for GluN2B-containing receptors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28586221      PMCID: PMC5916808          DOI: 10.1021/acs.jmedchem.7b00239

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  86 in total

Review 1.  Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.

Authors:  Daniel T Monaghan; Mark W Irvine; Blaise Mathias Costa; Guangyu Fang; David E Jane
Journal:  Neurochem Int       Date:  2012-01-17       Impact factor: 3.921

2.  Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors.

Authors:  D J Wyllie; P Béhé; D Colquhoun
Journal:  J Physiol       Date:  1998-07-01       Impact factor: 5.182

3.  Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.

Authors:  Timothy M Acker; Hongjie Yuan; Kasper B Hansen; Katie M Vance; Kevin K Ogden; Henrik S Jensen; Pieter B Burger; Praseeda Mullasseril; James P Snyder; Dennis C Liotta; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2011-08-01       Impact factor: 4.436

4.  Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.

Authors:  Matthew Volgraf; Benjamin D Sellers; Yu Jiang; Guosheng Wu; Cuong Q Ly; Elisia Villemure; Richard M Pastor; Po-wai Yuen; Aijun Lu; Xifeng Luo; Mingcui Liu; Shun Zhang; Liang Sun; Yuhong Fu; Patrick J Lupardus; Heidi J A Wallweber; Bianca M Liederer; Gauri Deshmukh; Emile Plise; Suzanne Tay; Paul Reynen; James Herrington; Amy Gustafson; Yichin Liu; Akim Dirksen; Matthias G A Dietz; Yanzhou Liu; Tzu-Ming Wang; Jesse E Hanson; David Hackos; Kimberly Scearce-Levie; Jacob B Schwarz
Journal:  J Med Chem       Date:  2016-03-08       Impact factor: 7.446

5.  Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid.

Authors:  Blaise Mathias Costa; Mark W Irvine; Guangyu Fang; Richard J Eaves; Maria Belen Mayo-Martin; Bodo Laube; David E Jane; Daniel T Monaghan
Journal:  Neuropharmacology       Date:  2011-12-06       Impact factor: 5.250

6.  Copper-catalyzed coupling of aryl iodides with aliphatic alcohols.

Authors:  Martina Wolter; Gero Nordmann; Gabriel E Job; Stephen L Buchwald
Journal:  Org Lett       Date:  2002-03-21       Impact factor: 6.005

7.  Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

Authors:  Adriana Feder; Michael K Parides; James W Murrough; Andrew M Perez; Julia E Morgan; Shireen Saxena; Katherine Kirkwood; Marije Aan Het Rot; Kyle A B Lapidus; Le-Ben Wan; Dan Iosifescu; Dennis S Charney
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596

8.  Correction to Synthesis and Structure Activity Relationship of Tetrahydroisoquinoline-Based Potentiators of GluN2C and GluN2D Containing N-Methyl-d-aspartate Receptors.

Authors:  Rose M Santangelo Freel; Kevin K Ogden; Katie L Strong; Alpa Khatri; Kathryn M Chepiga; Henrik S Jensen; Stephen F Traynelis; Dennis C Liotta
Journal:  J Med Chem       Date:  2014-05-30       Impact factor: 7.446

Review 9.  Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

Authors:  Penelope J Hallett; David G Standaert
Journal:  Pharmacol Ther       Date:  2004-05       Impact factor: 12.310

10.  NMDA receptor structures reveal subunit arrangement and pore architecture.

Authors:  Chia-Hsueh Lee; Wei Lü; Jennifer Carlisle Michel; April Goehring; Juan Du; Xianqiang Song; Eric Gouaux
Journal:  Nature       Date:  2014-06-22       Impact factor: 49.962

View more
  7 in total

1.  The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor.

Authors:  Thomas M Kaiser; Steven A Kell; Hirofumi Kusumoto; Gil Shaulsky; Subhrajit Bhattacharya; Matthew P Epplin; Katie L Strong; Eric J Miller; Bryan D Cox; David S Menaldino; Dennis C Liotta; Stephen F Traynelis; Pieter B Burger
Journal:  Mol Pharmacol       Date:  2017-12-14       Impact factor: 4.436

Review 2.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

3.  Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor.

Authors:  Matthew P Epplin; Ayush Mohan; Lynnea D Harris; Zongjian Zhu; Katie L Strong; John Bacsa; Phuong Le; David S Menaldino; Stephen F Traynelis; Dennis C Liotta
Journal:  J Med Chem       Date:  2020-07-06       Impact factor: 7.446

4.  Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl-d-aspartate Receptors.

Authors:  Katie L Strong; Matthew P Epplin; Kevin K Ogden; Pieter B Burger; Thomas M Kaiser; Timothy J Wilding; Hiro Kusumoto; Chad R Camp; Gil Shaulsky; Subhrajit Bhattacharya; Riley E Perszyk; David S Menaldino; Miranda J McDaniel; Jing Zhang; Phuong Le; Tue G Banke; Kasper B Hansen; James E Huettner; Dennis C Liotta; Stephen F Traynelis
Journal:  ACS Chem Neurosci       Date:  2020-12-16       Impact factor: 4.418

5.  A structurally derived model of subunit-dependent NMDA receptor function.

Authors:  Alasdair J Gibb; Kevin K Ogden; Miranda J McDaniel; Katie M Vance; Steven A Kell; Chris Butch; Pieter Burger; Dennis C Liotta; Stephen F Traynelis
Journal:  J Physiol       Date:  2018-08-01       Impact factor: 5.182

Review 6.  Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.

Authors:  Erica S Burnell; Mark Irvine; Guangyu Fang; Kiran Sapkota; David E Jane; Daniel T Monaghan
Journal:  J Med Chem       Date:  2018-03-05       Impact factor: 7.446

7.  LFZ-4-46, a tetrahydroisoquinoline derivative, induces apoptosis and cell cycle arrest via induction of DNA damage and activation of MAPKs pathway in cancer cells.

Authors:  Lili Xu; Guozheng Huang; Zhihui Zhu; Shasha Tian; Yingying Wei; Huanwu Hong; Xiaowei Lu; Ying Li; Feize Liu; Huajun Zhao
Journal:  Anticancer Drugs       Date:  2021-09-01       Impact factor: 2.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.